Mineralys (MLYS) news
Recent news
Mineralys Therapeutics prices offer of 5.66M shares at $26.50/share
Mineralys Therapeutics, Inc. (Nasdaq: MLYS) has priced a public offering of 5,660,000 shares of its common stock at $26.50 per share, according to a recent announcement. The offering is part of the company’s ongoing efforts to raise capital for the development of its lead drug candidate,…
AInvest Wire · Jun 3, 2026Mineralys Therapeutics prices $150M offering of stock
AInvest Wire · Jun 3, 2026Mineralys entered into up to $500M term loan agreement
AInvest Wire · Jun 3, 2026Mineralys will make $200M upfront payment
Mineralys Therapeutics, Inc. (Nasdaq: MLYS) has announced a $200 million upfront payment as part of a recent public offering, marking a significant milestone in the company’s capital-raising efforts. The funds were raised through the exercise of the underwriters’ option to purchase additional…
AInvest Wire · Jun 3, 2026Mineralys repurchases potential royalty payments due to Tanabe
AInvest Wire · Jun 3, 2026Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.